We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$99.2M
(+20%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
710
New
83
Increased
162
Reduced
252
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$19.1M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$14.1M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
+$14M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$10.8M |
| 5 |
iShares MSCI Thailand ETF
THD
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$16.7M |
| 2 |
Rogers Communications
RCI
|
+$6.28M |
| 3 |
TechnipFMC
FTI
|
+$5.75M |
| 4 |
PepsiCo
PEP
|
+$4.71M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.52% |
| 2 | Financials | 9.27% |
| 3 | Communication Services | 8.11% |
| 4 | Technology | 7.63% |
| 5 | Materials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Northern Trust
NTRS
$22.2B
| $220K | 0.04% |
+2,104
| New | +$223K |
|
|
EVHC
252
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $218K | 0.04% |
4,945
-10,501
| -68% | -$431K |
|
253
Wintrust Financial
WTFC
$10.7B
| $218K | 0.04% |
2,455
-586
| -19% | -$53.8K |
|
254
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.15B
| $218K | 0.04% |
+9,900
| New | +$231K |
|
255
Texas Capital Bancshares
TCBI
$4.31B
| $217K | 0.04% |
2,330
-582
| -20% | -$56.4K |
|
|
AMTD
256
DELISTED
TD Ameritrade Holding Corp
AMTD
| $215K | 0.04% |
3,868
-1,814
| -32% | -$108K |
|
257
Willis Towers Watson
WTW
$27.9B
| $214K | 0.04% |
+1,400
| New | +$213K |
|
258
Applied Materials
AMAT
$426B
| $214K | 0.04% |
4,593
+1,192
| +35% | +$61.4K |
|
259
PUT
Merck
MRK
$324B
| $210K | 0.04% |
+367
| New | +$20.7K |
|
260
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$166M
| $210K | 0.04% |
7,185
| – | – |
|
261
Advanced Micro Devices
AMD
$851B
| $208K | 0.03% |
13,854
-60,560
| -81% | -$770K |
|
262
The Bancorp
TBBK
$2.79B
| $207K | 0.03% |
+19,582
| New | +$215K |
|
263
Tesla
TSLA
$1.24T
| $205K | 0.03% |
8,985
-42,990
| -83% | -$874K |
|
264
Valero Energy
VLO
$89.8B
| $203K | 0.03% |
1,824
-25,051
| -93% | -$2.81M |
|
|
265
Freeport-McMoran
FCX
$90B
| $200K | 0.03% |
11,614
-987,200
| -99% | -$16.7M |
|
266
Atlantic Union Bankshares
AUB
$5.99B
| $199K | 0.03% |
+5,000
| New | +$197K |
|
|
B
267
Barrick Mining
B
$62.2B
| $195K | 0.03% |
15,046
-219,840
| -94% | -$2.88M |
|
268
Bread Financial
BFH
$4.21B
| $194K | 0.03% |
1,034
-414
| -29% | -$70.7K |
|
269
Enbridge
ENB
$124B
| $193K | 0.03% |
5,835
| – | – |
|
270
Ciena
CIEN
$55.3B
| $190K | 0.03% |
+7,181
| New | +$182K |
|
271
Sarepta Therapeutics
SRPT
$1.66B
| $185K | 0.03% |
+1,400
| New | +$132K |
|
|
VIAB
272
DELISTED
Viacom Inc. Class B
VIAB
| $177K | 0.03% |
5,851
-3,062
| -34% | -$90.1K |
|
273
Becton Dickinson
BDX
$43.1B
| $176K | 0.03% |
749
+11
| +1% | +$2.45K |
|
|
CNH
274
CALL
CNH Industrial
CNH
$13.8B
| $175K | 0.03% |
+142
| New | +$1.47K |
|
|
CNH
275
PUT
CNH Industrial
CNH
$13.8B
| $175K | 0.03% |
217
-139
| -39% | -$1.44K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2018 Portfolio in Review
As of Q2 2018, Exane Derivatives held 710 positions worth $599M, up 20% from $500M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives deployed $49.8M of net new capital in Q2 2018, opening 83 new positions and adding to 162 existing holdings. Its largest new stake was UBS Group: 1,172,516 shares worth $18.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $16.7M trimmed.
- Exane Derivatives's largest Q2 2018 buy was UBS Group: 1,172,516 shares worth $18.1M.
- Exane Derivatives added most to VanEck Russia ETF in Q2 2018, an estimated $14.1M increase.
- Exane Derivatives's biggest Q2 2018 reduction was Freeport-McMoran, cutting an estimated $16.7M.
- Exane Derivatives fully exited Rogers Communications in Q2 2018, selling an estimated $6.28M.
- Exane Derivatives's ten largest holdings make up 35% of its $599M portfolio in Q2 2018.
- Exane Derivatives opened 83 new positions and closed 24 in Q2 2018.
- Exane Derivatives's portfolio value rose 20% quarter-over-quarter to $599M.
Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.